People who stacked psilocybin with other substances like these were less likely to drink alcohol or smoke cigarettes as well. The post Psychedelic Stacking...
Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being,...
The article News You Might Have Missed: Sep 19th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly...
A jump in research studies sparks increased educational programs. The post The Future Psychedelics Workforce is Getting Schooled Today appeared first on...
PharmaTher Holdings Ltd. (OTCQB: PHRRF | CSE: PHRM), a leader in specialty ketamine pharmaceuticals, today announced that the Phase 1/2 clinical Study...
Oral psilocybin film-strips to treat could conduct the first-in-human clinical study as soon as next year. The post Revive Therapeutics Gets Nod From FDA,...
Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely...
The article A Look at MAPS’ Phase 3 Trials was originally published on Microdose. The first of The Multidisciplinary Association for Psychedelic’s...
Several academic institutions around the world are heeding the call to quickly build a psychedelics workforce. The post Future Psychedelics Workforce Getting...
The FDA has started a priority review of Chiesi ‘s velmanase alfa, an enzyme replacement therapy for lysosomal The post FDA starts review of first drug...